> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Awards 5 Biosimilars Research Grants
- URL: https://www.fdaweb.com/fda-awards-5-biosimilars-research-grants/
- Published: 2022-10-19T12:00:00.000Z
- Updated: 2026-09-14T18:03:41.000Z
- Author: David McFarland
- Tags: Biologics, #legacy-id-D5153006

FDA has [announced](https://www.fda.gov/media/162361/download?ref=fdaweb.com) five research grants made under the Biosimilar User Fee Act (BsUFA) research grant program in the areas of **(1)** improving the efficiency of biosimilar product development and **(2)** advancing the development of interchangeable products. The five grants are:

- assessment of the performance of multi-attribute method versus conventional quality control methods for evaluation of product quality attributes of adalimumab and etanercept;
- platform for reliable characterization and evaluation of comparability of biosimilar drug products in lyophilized and liquid formulations;
- systematic analytical characterization of innovator and biosimilar products with the focus on post-translational modifications;
- ISPRI-HCP: CHO protein impurity immunogenicity risk prediction for improving biosimilar product development and assessing product interchangeability; and
- improving the efficiency of regulatory decisions for biosimilars and interchangeable biosimilars by leveraging real-world data.